tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vitura Health Names Andrew Cook as New Chief Financial Officer

Story Highlights
  • Vitura Health has appointed Andrew Cook as Chief Financial Officer, starting in Q3 FY2026.
  • Cook’s extensive senior finance experience is expected to bolster Vitura’s growth in digital health and medicinal cannabis platforms.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vitura Health Names Andrew Cook as New Chief Financial Officer

Claim 50% Off TipRanks Premium

An announcement from Cronos Australia Ltd. ( (AU:VIT) ) is now available.

Vitura Health Limited has appointed experienced finance executive Andrew Cook as its new Chief Financial Officer, with the Queensland-based Chartered Accountant expected to commence in the role in the third quarter of FY2026. With more than two decades of senior finance experience across major organisations including Energy Queensland, Origin Energy, SABMiller and most recently as CFO and Company Secretary of AnteoTech Limited, Cook is expected to strengthen Vitura’s financial leadership as it pursues its strategic priorities in digital health, medicinal cannabis distribution and psychedelic therapies, supporting the company’s efforts to scale its integrated health platforms and deliver long-term value to shareholders.

The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.

More about Cronos Australia Ltd.

Vitura Health Limited is an ASX-listed diversified digital health business focused on medicinal cannabis distribution, telehealth and emerging psychedelic therapies in Australia. Through subsidiaries including Burleigh Heads Cannabis and its Canview platform, the company operates a leading online ecosystem connecting prescribers, patients, pharmacies and suppliers, currently distributing more than 430 therapeutic product and device SKUs from about 60 brands via two licensed distribution centres. Vitura also owns nationwide telehealth provider Doctors on Demand, medicinal cannabis clinics CDA Clinics and Cannadoc, and holds a 50% stake in Cortexa, a joint venture aiming to supply GMP-grade MDMA and psilocybin for research and therapeutic use in Australia.

Average Trading Volume: 243,205

Technical Sentiment Signal: Sell

Current Market Cap: A$39.1M

For detailed information about VIT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1